testing testing

Engineer, Entrepreneur, Investor

[testing testing @testing85101447]

Under the new @realDonaldTrump administration and the techno king, the GREAT @elonmusk, this drug can be approved by June of 2025. If $SAVA drug can confirm benefits just for MILDS ALZ Patients in P3, the new @US_FDA under @TeamTrump will not leave a stone unturned to fast track

[Matt Nachtrab @MattNachtrab]

RETHINK phase 3 reads out by Cassava Sciences, $sava, around December 18th of 2024. We know the drug is safe, so it comes down to effectiveness that could be demonstrated in the RETHINK readout.

Here are my price estimates depending on data:

1. RETHINK does not show stat sig improvement in mild or moderate - Price will likely goto $10 or lower and wait for REFOCUS, but not good and shorts win. 5% chance this happens

2. RETHINK shows stat sig for Mild and not for moderate and not for total. Lets say Mild slows decline by 30% or similar to $lly and $Biib MAB treatments. Stock will goto $50+ after readout then drift up toward a $10B market cap or $250. 5% chance this happens

3. RETHINK beats the MABS and slows mild patients cognition 50% better than placebo. Moderate not significant and total not significant. The stock should goto $80+ then drift to $350 because it will be a blockbuster. 5% chance this happens.

4. RETHINK reads out MILD as improvement in cognition, so a 100% or greater than placebo. Moderate not significant, but overall is significant. Stock should goto $200 instantly, then drift up to $500+. Proves that if you take simufilam early you will not get AD symptoms. 20% chance this happens

5. RESULT I EXPECT - RETHINK reads out as Mild improvement AND Moderate better than placebo. So Mild's improve over 100% to placebo and moderate improve 30-50% decline than placebo. Stock will instantly goto $300 plus and drift toward $2000. Mega blockbuster drug, but slower uptake. 35% chance this happens

6. RETHINK on average improves the entire treatment group cognition at 1 year, so improvement over placebo > 100%. Stock will instantly goto 500 and rise toward $3000+. Mega blockbuster drug that solves the AD crisis and world wide medical and government will get behind getting the drug out as fast as possible. 30% chance this happens.

There are more scenarios based on the 2 different primary endpoints. It's hard not to seem crazy when you put out potential values 10-100x the current stock price. Look at the TAM in the image though... Also, Rick Barry just said on the conference call that the actual patient population is DOUBLE because he says that Primary Care Physicians only diagnose 50% of AD patients. They are doing commercialization planning right now. The TAM could be double this...

There are so many variables at this point on pricing, diagnosis technology and etc. I think the treatment effects, ease of administration, and safety profile will quickly become known to ALL families affected by #Alzheimers around the world. The small molecule pill is EASY to scale. I think that the patient and trial site personal interviews are not ONE OFF, but PERVASIVE in the trial. This stock is a raging buy at $26.

More background... read here: https://t.co/nxDpOaOx03

I started a non-profit to help keep scientists focused on finding cures to disease and fight off the online, media and ethics harassments. If you want to donate to https://t.co/IMixWEsy7S

[testing testing @testing85101447]

@mitchellvii Corridor

[testing testing @testing85101447]

@elonmusk @SpaceX What happened to the ship?

[testing testing @testing85101447]

Check out $FRSX small AI AUTONOMOUS company that will benefit from @realDonaldTrump Policy and is already SQUEEZING . A chance to make up $SAVA losses

[Tiffiny Fawcett @tiffinyfawcett]

$QS 18% 😉🔥

[testing testing @testing85101447]

@TEXTILE_FIBER Lol

[testing testing @testing85101447]

@CaliRomo Thank you for posting

[testing testing @testing85101447]

@Stetson_100X @MattNachtrab I like the sound of that

[testing testing @testing85101447]

@MattNachtrab , Please respond to SAVA CLARITY. I think he brings valid points.
https://t.co/SkWEijJIz6

[testing testing @testing85101447]

@MattNachtrab I'm hoping that THIS time will break their back

[testing testing @testing85101447]

@rdohnethook @PK_Fund It sure seems that way, and the shorts starting to realize

[testing testing @testing85101447]

@MattNachtrab If Landen -reputable Scientist-was actually hired back in September, and we only hear about it now, this can only mean $SAVA must have already seen the locked data and they liked what they saw.

[testing testing @testing85101447]

Fuck this Dirty Log

[Tiffiny Fawcett @tiffinyfawcett]

$SAVA 43% no shares left they are actually letting it move like it should daily… likely to squeeze retail out😂🔥

[testing testing @testing85101447]

@anyones2cents How about Melissa London?

[testing testing @testing85101447]

@anyones2cents How do we know it's her?

[testing testing @testing85101447]

@Sbell68 @f1_racing_fan @LogarithmicDis Fugly inside out

[testing testing @testing85101447]

I can't believe what I'm reading, change is finally coming to @US_FDA to pave the way for innovative drugs to save lives. $SAVA

[Vivek Ramaswamy @VivekGRamaswamy]

My #1 issue with FDA is that it erects unnecessary barriers to innovation (e.g. two replicate phase 3 studies instead of one, refusal to accept valid clinical results from other nations, etc.). This stops patients from accessing promising therapies & raises prescription drug costs by impeding competition. The agency’s staff have callous disregard for the impact of their daily decisions on the cost of developing new therapies, which inevitably gets passed on to the healthcare system. *That’s* the actual problem with FDA & it’s the one we should be talking more about.

[testing testing @testing85101447]

Music to my ear, listen to Suzanne Hendrix talking about $SAVA drug "Based on the comparison to the historic data you can tell that's pretty unusual to have that much stabilization over that long of a time" Fck you log
https://t.co/myuTJcQ8zP

[testing testing @testing85101447]

I see stars are aligning for $SAVA , the drug is already SAFE, Efficacy is confirming what we already know, @realDonaldTrump is NOT afraid to cut through any red tape to get drugs out of @US_FDA congested and outdated approval pipeline https://t.co/vixI5Xin7L

[testing testing @testing85101447]

@MattNachtrab @ChrisRock002 While Log is frantically responding to anyone and everyone posting about the testimonial, doxxing the family, posting their LinkedIn info and generally being a toxic human, I hope the rest of yall have a good weekend and hug your loved ones.

[testing testing @testing85101447]

@afzaalm @adamfeuerstein I Agree, Data is LOCKED